Dramatic response of malignant craniopharyngioma to cis-platin-based chemotherapy. Should craniopharyngioma be considered as a suprasellar 'germ cell' tumour?

References

• Cushing H. The craniopharyngiomas, in: Intracranial tumors. Notes upon a series of two thousand verified cases with surgical mortality percentage. Illinois: Thomas Springfield, 1932:93–8.
   Google Scholar
• Heidemann RL,, Packer RJ, Albright LA, Freeman CR, Rorke LB. Tumors of the central nervous system, in: Pizzo PA, Poplak DG (eds) Principles and practice of pediatric oncology. Philadelphia: Lippincott-Raven, 1997:633–97.
   Google Scholar
• Salyer D, Carter D. Squamous carcinoma arising in the pituitary gland. Cancer 1973;31:713–8.
   PubMedGoogle Scholar
• Nelson GA, Bastian FO, Schlitt M, White RL. Malignant transformation in craniopharyngioma. Neurosurgery 1988;22: 427–9.
   PubMedGoogle Scholar
• Kristopaitis T, Thomas C, Petruzella GJ, Lee JM. Malignant craniopharyngioma. Arch Pathol Lab Med 2000;124:1356–60.
   PubMedGoogle Scholar
• Harris PE, Perry L, Chard T, et al. Immunoreactive human chorionic gonadotrophin from the cyst fluid and CSF of patients with craniopharyngioma. Clin Endocrinol 1988;29: 503–8.
   PubMedGoogle Scholar
• Janmohamed S, Grossman AB, Metcalfe K, et al. Suprasellar germ cell tumours - specific problems and the evolution of optimal management with a combined chem.-radiotherapy regimen. Clin Endocrinol 2002;57:487–500.
   PubMedGoogle Scholar
• Summersgill B, Goker H, Osin P, et al. Establishing germ cell origin of undifferentiated tumors by identifying gain of 12p material using comparative genomic hybridization analysis of paraffin-embedded samples. Diagn Mol Pathol 1998;7:260–6.
   PubMedGoogle Scholar
• Summersgill B, Goker H, Weber-Hall S, Huddart R, Horwich A, Shipley J. Molecular cytogenetic analysis of adult testicular germ cell tumours and identification of regions of consensus copy number change. BrJ Cancer 1998;77:305–13.
   Google Scholar
• Cohnheim J. Vorlesungen uber algemeine Pathologie, erster Band. Berlin: Hirschwald, 1882.
   Google Scholar
• Freidman NB, Moore AB. Tumors of the testis-a report on 922 cases. Mil Surgeon 1946;99:573–93.
   PubMedGoogle Scholar
• Dixon FJ, Moore RA. Testicular tumours-a clinicopatholo-gical study. Cancer 1953;6:427–54.
   PubMed Web of Science ®Google Scholar
• Teilum G. Classification of endodermal sinus tumor (mewso-blastoma vitellinum) and so-called embryonal carcinoma of the ovary. Acta Pathol Microbiol Scand 1965;64:407–29.
   PubMedGoogle Scholar
• Sano K. So called intracranial germ cell tumours: are they really of germ cell origin? Br I Neurosurg 1995;9:391–401.
   PubMedGoogle Scholar
• Sano K. Intracranial dysembryogenetic tumours: pathogenesis and their order of malignancy. Neurosurg Rev 2001;24:162–7.
   PubMedGoogle Scholar
• Netsky MG. Epidermoid tumors. Review of the literature. Surg Neurol 1998;29:477–83.
   Google Scholar
• Stevens LC. Experimental production of testicular teratomas in mice. Proc Natl Acad Sci USA 1964;52:654–61.
   PubMed Web of Science ®Google Scholar
• Atkin NB, Baker MC. I(12p): specific chromosome marker in seminoma and teratoma of testis? Cancer Genet Cytogenet 1983; 10:199–204.
   PubMedGoogle Scholar
• Chaganti RS, Rodriguez E, Mathew S. Origin of adult male mediastinal germ-cell tumours. Lancet 1994;343:1130–2.
   Google Scholar
• Motzer RJ, Rodriguez E, Reuter VE, et al. Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. I Clin Oncol 1995;13:274–82.
   PubMedGoogle Scholar
• Stock C, Strehl S, Fink FM, et al. Isochromosome 12p and maternal loss of 1p36 in pediatric testicular germ cell tumor. Cancer Genet Cytogenet 1996;91:95–100.
   PubMedGoogle Scholar
• Bussey KJ, Lawce HJ, Olson SB, et al. Chromosome abnormalities of eighty one pediatric germ cell tumors: sex-, age-, site-, and histopathology-related differences-a Children's Cancer Group Study. Genes, Chromos Cancer 1999;25:134–46.
   PubMedGoogle Scholar
• Silver SA, Wiley JM, Perlman EJ. DNA ploidy analysis of pediatric germ cell tumors. Mod Pathol 1994;7:951–6.
   Google Scholar
• Schneider DT, Schuster AE, Fritsch MK, et al. Genetic analysis of mediastinal nonseminomatous germ cell tumors in children and adolescents. Genes Chroms Cancer 2002;34:115–25.
   PubMedGoogle Scholar
• Schneider DT, Schuster AE, Fritsch MK, et al. Genetic analysis of childhood germ cell tumors with comparative genomic hybridization. Kin Padiatr 2001;213:204–11.
   PubMedGoogle Scholar
• Yu TT, Griffin CA, Phillips PC, Strauss LC, Perlman EJ. Numerical sex chromosomal abnormalities in pineal teratomas by cytogenetic analysis and fluorescence in situ hybridisation. Lab Invest 1995;72:419–23.
   Google Scholar
• Okada Y, Nishikawa R, Matsutari M, Louis DN. Hypomethy-lated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors. I Neuropathol Exper Neurol 2002;61:531–81.
   PubMed Web of Science ®Google Scholar
• Lemos R, Barbieri-Neto J, Casartelli C. Primary intracranial germ cell tumours without an isochrome 12p. Cancer Genet Cytogenet 1998;100:124–8.
   PubMedGoogle Scholar
• Rickert CH, Paulus W. Lack of chromosomal imbalances in adamantinomatous and papillary craniopharyngioma. 3 Neurol Neurosurg Psychiatry 2003;74:260–1.
   PubMedGoogle Scholar
• Rienstein S, Adams EF, Pilzer D, et al. Comparative genomic hybridization analysis of craniopharyngiomas. 3 Neurosurg 2003;98:162–4.
   PubMed Web of Science ®Google Scholar
• Gorski GK, McMorrow LE, Donaldson MH, Freed M. Multiple chromosomal abnormalities in a case of craniophar-yngioma. Cancer Genet Cytogenet 1992;60:212–13.
   PubMedGoogle Scholar
• Karnes PS, Tran TN, Cui MY, et al. Cytogenetic analysis of 39 pediatric central nervous system tumors. Cancer Genet Cyto-genet 1992;59:12–19.
   PubMed Web of Science ®Google Scholar
• Riou G, Barrios M, Prost S, et al. The p53 and mdm-2 genes in human testicular germ cell tumors. Mol Carcinogenesis 1995;12:124–31.
   PubMed Web of Science ®Google Scholar
• Mueller T, Voigt W, Simon H, et al. Failure of activation of caspase-9 induces a higher threshold for apoptosis and cisplatin resistance in testicular cancer. Cancer Res 2003;63:513–21.
   PubMed Web of Science ®Google Scholar
• Nada R, Mohan H, DhirKak VK. Suprasellar malignantmixed germ cell tumour presenting as craniopharyngioma. Neurol India 2000;48:381–4.
   Google Scholar
• Mottolese C, Stan H, Hermier M, et al. Intracystic chemother-apy with bleomycin in the treatment of craniopharyngiomas. Child Nerv Syst 2001;17:724–30.
   PubMedGoogle Scholar
• Park DH, Park JY, Kim JH, et al. Outcome of postoperative intratumoral bleomycin injection for cystic craniopharyngio-ma. I Kor Med Sci 2002;17:254–9.
   PubMedGoogle Scholar
• Takahashi H, Nakazawa S, Shimira T. Evaluation of intracra-nial injection of bleomycin for craniopharyngioma of child-hood. JNeurosurg 1985;62:120–8.
   Google Scholar
• Bremer Am, Nguyen TQ, Balsyo R. Therapeutic benefits of combination chemotherapy with vincristine, BCNU and procarbazine on recurrent cystic craniopharyngioma. I Neu-roncol 1994;2:47–50.
   Google Scholar
• Lippens RJ, Rotteveel jj, Otten BJ, Merx H. Chemotherapy with adriamycin (doxorubicin) and CCNU (lomustine) in four children with recurrent craniopharyngioma. Eur 3 Paed Neurol 1998;2:263–8.
   PubMedGoogle Scholar
• Plowman PN, Kingston JE, Sebag-Montefiore DS, Doughty D. Clinical efficacy of perceived `CNS friendly' chemo-radiotherapy for primary intracranial germ cell tumour. Clin Oncol 1997;9:48–53.
   Google Scholar